Two-year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids: A randomized, double-blind, placebo-controlled extension trial

✍ Scribed by Jonathan D. Adachi; Kenneth G. Saag; Pierre D. Delmas; Uri A. Liberman; Ronald D. Emkey; Ego Seeman; Nancy E. Lane; Jean-Marc Kaufman; Patrice E. E. Poubelle; Federico Hawkins; Ricardo Correa-Rotter; Charles-Joel Menkes; Jose A. Rodriguez-Portales; Thomas J. Schnitzer; Joel A. Block; Jeffrey Wing; Harris H. McIlwain; Rene Westhovens; Jacques Brown; Jose A. Melo-Gomes; Barry L. Gruber; Melissa J. Yanover; Maria Odette R. Leite; Kerry G. Siminoski; Michael C. Nevitt; John T. Sharp; Marie-Pierre Malice; Thomas Dumortier; Michelle Czachur; Wendy Carofano; Anastasia Daifotis

• Publisher: John Wiley and Sons
• Year: 2001
• Tongue: English
• Weight: 114 KB
• Volume: 44
• Category: Article
• ISSN: 0004-3591
• DOI: 10.1002/1529-0131(200101)44:1<202::aid-anr27>3.0.co;2-w